Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hepatic fibrosis: molecular mechanisms and drug targets.
Lotersztajn S, Julien B, Teixeira-Clerc F, Grenard P, Mallat A. Lotersztajn S, et al. Annu Rev Pharmacol Toxicol. 2005;45:605-28. doi: 10.1146/annurev.pharmtox.45.120403.095906. Annu Rev Pharmacol Toxicol. 2005. PMID: 15471534 Review.
Antifibrogenic role of the cannabinoid receptor CB2 in the liver.
Julien B, Grenard P, Teixeira-Clerc F, Van Nhieu JT, Li L, Karsak M, Zimmer A, Mallat A, Lotersztajn S. Julien B, et al. Gastroenterology. 2005 Mar;128(3):742-55. doi: 10.1053/j.gastro.2004.12.050. Gastroenterology. 2005. PMID: 15765409
The sphingosine 1-phosphate receptor S1P2 triggers hepatic wound healing.
Serriere-Lanneau V, Teixeira-Clerc F, Li L, Schippers M, de Wries W, Julien B, Tran-Van-Nhieu J, Manin S, Poelstra K, Chun J, Carpentier S, Levade T, Mallat A, Lotersztajn S. Serriere-Lanneau V, et al. FASEB J. 2007 Jul;21(9):2005-13. doi: 10.1096/fj.06-6889com. Epub 2007 Mar 6. FASEB J. 2007. PMID: 17341687
[Endocannabinoids: therapeutic perspectives in chronic liver diseases].
Lotersztajn S, Teixeira-Clerc F, Hezode C, Tran van Nhieu J, Deveaux V, Mallat A. Lotersztajn S, et al. Gastroenterol Clin Biol. 2007 Mar;31(3):255-8. doi: 10.1016/s0399-8320(07)89369-9. Gastroenterol Clin Biol. 2007. PMID: 17396081 Free article. French. No abstract available.
CB2 receptors as new therapeutic targets for liver diseases.
Lotersztajn S, Teixeira-Clerc F, Julien B, Deveaux V, Ichigotani Y, Manin S, Tran-Van-Nhieu J, Karsak M, Zimmer A, Mallat A. Lotersztajn S, et al. Br J Pharmacol. 2008 Jan;153(2):286-9. doi: 10.1038/sj.bjp.0707511. Epub 2007 Oct 22. Br J Pharmacol. 2008. PMID: 17952109 Free PMC article. Review.
30 results